D. Reske

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Ludwig Kappos, Gilles Edan, Mark S. Freedman et al. · Neurology · 2016 · 130 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +13

Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis

Hela-Felicitas Petereit, D. Reske, Hayrettin Tumani et al. · Journal of Neurology · 2010 · 72 citations

Life Sciences, Neurology, Neuroscience +12

Rituximab in a patient with multiple sclerosis - effect on B cells, plasma cells and intrathecal IgG synthesis

H.-F. Petereit, Walter Moeller‐Hartmann, D. Reske et al. · Acta Neurologica Scandinavica · 2007 · 59 citations

Life Sciences, Immunology, Neurology +17

Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients – follow-up and clinical implications

Hela-Felicitas Petereit, D. Reske · Cerebrospinal Fluid Research · 2005 · 41 citations · Full text

Life Sciences, Immunology, Neurology +15

Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia – a single center experience on 160 patients

J. Thiele, Kvasnicka Hm, DW Beelen et al. · Bone Marrow Transplantation · 2000 · 23 citations

Medicine, Hematology, Immunology +17